Table 3.
Sample | NF1 mutations | RASopathy gene mutations |
---|---|---|
YUBER | p.Arg262Cys, p.Trp784* | SOS1 G434R |
YUCAS | p.Ile679AspfsX21 | – |
YUDAB | p.Phe1464Leu | PTPN11 Q506P |
YUFIGUR | p.Tyr628LeufsX6, p.Gln2234* | – |
YUHEF | p.Lys2552ThrfsX2, p.Gln853* |
SOS1G434V,R398H,P102S, RAF1P261L |
YUKAT | p.Trp9*, p.Gln2239* | SOS1 R1067G |
YUKAY | p.Arg1534* | – |
YUKLAB | p.Ser2025Leu,
p.Arg1204Trp, p.Arg416* |
PTPN11P491L,Q510L,D425N, RASA2P530L |
YULAN | NF1: c.6819+1G>A, p.Pro1084Ser | – |
YUMUJ | p.Lys1632MetfsX8 | PTPN11 A461T |
YUNEKI | p.Gln803* | – |
YUOMEGA | p.Asn793LysfsX14, p.Leu844Phe | SPRED1 R117Q |
YUOTHO | p.Gln1010*, pGln2239* | RASA2 S400F |
YUPADI | p.Ser2093Phe, p.Arg1362* | SPRED1 Q353* |
YUPAER | p.Gln912* | – |
YUPAT | p.Leu844Phe | – |
YUPROST | p.Arg440* | RASA2 R310* |
YURAY | p.Arg2450* | – |
YUROG | p.Gln1218* | – |
YUROO | p.Gln282*, p.Arg440* p.Leu2661* | RASA2 F585I |
YURUS | p.Gln2434* |
RASA2R511C,P843S, SPRED1Q205* |
YUSOC | p.Glu337Lys, pTrp336* | RASA2R511C,Q500*, RAF1T491I |
YUTAR | p.Val2653SerfsX26 | RASA2 R511C |
YUTOGS | p.Leu466Phe, p.Lys2535* | – |
YUWAND | p.Phe694_Trp696del | PTN11Y279C, SOS1R552K |
YUZAN | p.Met108Ile | – |
Mutations in RASA2 (pArg511Cys), PTPN11 (p.Tyr279Cys, p.Ala461Thr, p.Pro491Leu, p.Gln506Pro), SOS1 (p.Gly434Arg, p.Arg552Lys) and RAF1 (p.Pro261Leu, p.Thr491Ile) have been previously shown to be disease causing in RASopathy syndromes (see text for details).